GSTM5 and urinary bladder cancer: As high GSTM5 expression was associated with a higher probability of relapse-free survival, in the future, increasing GSTM5 expression may be a consideration for bladder cancer therapy, and GSTM5 DNA methylation level may be a useful biomarker for patients with bladder cancer.